~~<i id='FFE35FA697'><strike id='FFE35FA697'><tt id='FFE35FA697'><pre id='FFE35FA697'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：comprehensive 2025-09-30 17:05:25 - browse：871

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： In same hospitals, Black patients receive fewer opioids than white patients

focus

hotspot

entertainment

focus

AdobeAbipartisangroupofsenatorsthisweekintroducedabillthatwouldpermanentlyallowhealthproviderstopres

WSS

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

The health care issue Democrats can’t solve: hospital reform

Medicare must police algorithms in Medicare Advantage, Dems say

Police still searching for prisoner who escaped from NYC hospital

Gene therapy’s promise and the high cost of hope

What is microchimerism and how does it affect maternal health?

focus

Wikipedia

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

After Sarepta trial failure, Duchenne families brace for more debate

The cancer drug shortage isn’t new — and neither are the solutions

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Explaining an after

Medical leaders decry Supreme Court decision on affirmative action

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Medicare details structure of new drug price negotiation program

Life sciences investors close nearly $6 billion in new funds

hotspot

Key Senate panel to consider PBM, drug pricing reform package

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

The health care issue Democrats can’t solve: hospital reform

The best solution to the drug shortages problem

Inari Medical to buy amputation prevention company LimFlow

The best solution to the drug shortages problem

hotspot

entertainment

entertainment

focus